Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus
This study has been completed.
Study NCT00496821.   Last updated on November 29, 2007.
Information provided by Alnylam Pharmaceuticals
Please refer to this study by its ClinicalTrials.gov identifier: NCT00496821
Locations
United States, Massachusetts
Alnylam Pharmaceuticals
Cambridge, Massachusetts, United States, 02142
Sponsors and Collaborators
Alnylam Pharmaceuticals
Investigators
Study Director: Akshay Vaishnaw, MD PhD Alnylam Pharmaceuticals




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services